Literature DB >> 16356945

Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use.

Nicola Low1, Anne McCarthy, Tracy E Roberts, Mia Huengsberg, Emma Sanford, Jonathan A C Sterne, John Macleod, Chris Salisbury, Karl Pye, Aisha Holloway, Andrea Morcom, Rita Patel, Suzanne M Robinson, Paddy Horner, Pelham M Barton, Matthias Egger.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a practice nurse led strategy to improve the notification and treatment of partners of people with chlamydia infection.
DESIGN: Randomised controlled trial.
SETTING: 27 general practices in the Bristol and Birmingham areas. PARTICIPANTS: 140 men and women with chlamydia (index cases) diagnosed by screening of a home collected urine sample or vulval swab specimen.
INTERVENTIONS: Partner notification at the general practice immediately after diagnosis by trained practice nurses, with telephone follow up by a health adviser; or referral to a specialist health adviser at a genitourinary medicine clinic. MAIN OUTCOME MEASURES: Primary outcome was the proportion of index cases with at least one treated sexual partner. Specified secondary outcomes included the number of sexual contacts elicited during a sexual history, positive test result for chlamydia six weeks after treatment, and the cost of each strategy in 2003 sterling prices.
RESULTS: 65.3% (47/72) of participants receiving practice nurse led partner notification had at least one partner treated compared with 52.9% (39/68) of those referred to a genitourinary medicine clinic (risk difference 12.4%, 95% confidence interval -1.8% to 26.5%). Of 68 participants referred to the clinic, 21 (31%) did not attend. The costs per index case were 32.55 pounds sterling for the practice nurse led strategy and 32.62 pounds sterling for the specialist referral strategy.
CONCLUSION: Practice based partner notification by trained nurses with telephone follow up by health advisers is at least as effective as referral to a specialist health adviser at a genitourinary medicine clinic, and costs the same. Trial registration Clinical trials: NCT00112255.

Entities:  

Mesh:

Year:  2005        PMID: 16356945      PMCID: PMC1325126          DOI: 10.1136/bmj.38678.405370.7C

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  15 in total

1.  A survey of contact tracing practice for sexually transmitted diseases in GUM clinics in England and Wales.

Authors:  T Stokes; P Schober
Journal:  Int J STD AIDS       Date:  1999-01       Impact factor: 1.359

2.  Modelling the healthcare costs of an opportunistic chlamydia screening programme.

Authors:  E J Adams; D S LaMontagne; A R Johnston; J M Pimenta; K A Fenton; W J Edmunds
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

3.  Chlamydia--a testing issue.

Authors: 
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

4.  Screening for chlamydia.

Authors:  John Macleod; Chris Salisbury; Nicola Low
Journal:  Lancet       Date:  2005 Apr 30-May 6       Impact factor: 79.321

5.  Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.

Authors:  Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes
Journal:  N Engl J Med       Date:  2005-02-17       Impact factor: 91.245

6.  Genital Chlamydia trachomatis infections in primary care.

Authors:  J D Ross; S Sutherland; J Coia
Journal:  BMJ       Date:  1996-11-09

7.  Knowledge of sex partner treatment for past bacterial STI and risk of current STI.

Authors:  L M Niccolai; J R Ickovics; K Zeller; T S Kershaw; S Milan; J B Lewis; K A Ethier
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

8.  Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study.

Authors:  John Macleod; Chris Salisbury; Nicola Low; Anne McCarthy; Jonathan A C Sterne; Aisha Holloway; Rita Patel; Emma Sanford; Andrea Morcom; Paddy Horner; George Davey Smith; Susan Skidmore; Alan Herring; Owen Caul; F D Richard Hobbs; Matthias Egger
Journal:  BMJ       Date:  2005-04-04

9.  Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.

Authors:  Jan E A M van Bergen; Maarten J Postma; Paul G H Peerbooms; Arie C Spangenberg; Jessica Tjen-A-Tak; Patrick J E Bindels
Journal:  Int J STD AIDS       Date:  2004-12       Impact factor: 1.359

10.  The chlamydia screening studies: rationale and design.

Authors:  N Low; A McCarthy; J Macleod; C Salisbury; P J Horner; T E Roberts; R Campbell; A Herring; S Skidmore; E Sanford; J A C Sterne; G Davey Smith; A Graham; M Huengsberg; J Ross; M Egger
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

View more
  21 in total

1.  NICE guidance on one-to-one interventions to reduce sexually transmitted infections and under-18 conceptions: a view from general practice.

Authors:  Pippa Oakeshott; Anna Graham
Journal:  Sex Transm Infect       Date:  2007-04       Impact factor: 3.519

2.  Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.

Authors:  Suzanne Robinson; Tracy Roberts; Pelham Barton; Stirling Bryan; John Macleod; Anne McCarthy; Matthias Egger; Emma Sanford; Nicola Low
Journal:  Sex Transm Infect       Date:  2007-01-17       Impact factor: 3.519

Review 3.  Vaginal discharge.

Authors:  Des Spence; Catriona Melville
Journal:  BMJ       Date:  2007-12-01

Review 4.  Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.

Authors:  T E Roberts; S Robinson; P Barton; S Bryan; N Low
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

Review 5.  Partner notification.

Authors:  Catherine Mathews; Nicol Coetzee
Journal:  BMJ Clin Evid       Date:  2009-05-20

6.  Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.

Authors:  Valentine Akande; Cathy Turner; Paddy Horner; Andrew Horne; Allan Pacey
Journal:  Hum Fertil (Camb)       Date:  2010-09       Impact factor: 2.767

Review 7.  Strategies for partner notification for sexually transmitted infections, including HIV.

Authors:  Adel Ferreira; Taryn Young; Catherine Mathews; Moleen Zunza; Nicola Low
Journal:  Cochrane Database Syst Rev       Date:  2013-10-03

Review 8.  Chlamydia (uncomplicated, genital).

Authors:  Paddy Horner
Journal:  BMJ Clin Evid       Date:  2008-06-23

9.  Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.

Authors:  Tracy E Roberts; Suzanne Robinson; Pelham M Barton; Stirling Bryan; Anne McCarthy; John Macleod; Matthias Egger; Nicola Low
Journal:  BMJ       Date:  2007-07-26

10.  Use of a primary care database to determine trends in genital chlamydia testing, diagnostic episodes and management in UK general practice, 1990-2004.

Authors:  Gwenda Hughes; Tim Williams; Ian Simms; Catherine Mercer; Kevin Fenton; Jackie Cassell
Journal:  Sex Transm Infect       Date:  2007-03-14       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.